E

KORU Medical Systems, Inc. KRMD

$3.16 $0.010.32% NASDAQ
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
Access our Premium Ratings
Get Access

Rating

Reward
Risk

Rating Factors

Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index

Company Overview

KORU Medical Systems, Inc. is a U.S.-based medical technology company focused on the development, manufacture, and commercialization of infusion solutions for subcutaneous drug delivery. The company operates within the broader healthcare and medical device industries, with a primary emphasis on specialty infusion therapy. KORU’s products are designed to facilitate the administration of biologic medications and immune globulin therapies in home-based and ambulatory care settings. The company’s core revenue drivers include its infusion pump systems, consumable infusion sets, and related accessories used in chronic therapy treatments.

KORU’s primary platform is its wearable and portable subcutaneous infusion technology, including the FREEDOM infusion system product line. The company serves pharmaceutical manufacturers, specialty pharmacies, home infusion providers, hospitals, and patients requiring long-term infusion therapy. KORU has positioned itself around the growing trend toward home-based care and patient self-administration, particularly for chronic immune deficiencies and neurological conditions treated with subcutaneous immunoglobulin (SCIg). Originally founded as Repro-Med Systems, Inc., the company later rebranded to KORU Medical Systems to reflect its broader strategic focus on patient-centric infusion technologies and pharmaceutical partnerships.

Data compiled by narrative technology. May contain errors.
Sector

Income Statement

Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)

Balance Sheet

Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)

Cash Flow

Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)

Filings

Filing Date
Wednesday, August 5, 2026
Period Date
Tuesday, June 30, 2026
Next Filing
Week of Nov 9 and 13 (est)

Price History

Loading...
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High

Valuation

Market Cap
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)

Dividends and Shares

Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--

Corporate Info

Phone Number
845 469 2042
Address
100 Corporate Drive
Mahwah, NJ 07430
Country
Year Founded

Headlines

8/22/2026 - Seeking Alpha - Long Ideas
8/22/2026 - Seeking Alpha - Healthcare